| Trial ID: | L1084 |
| Source ID: | NCT03202407
|
| Associated Drug: |
Calcium Acetate And Sevelamer Hydrochloride
|
| Title: |
Hyperphosphatemia in Children With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hyperphosphatemia
|
| Interventions: |
DRUG: Calcium acetate and sevelamer hydrochloride
|
| Outcome Measures: |
Primary: controlling of hyperphosphatemia, controlling abnormal laboratory parameters such as calcium, phosphate, and parathyroid hormone ., 3 months|Cardiovascular complications, Preventing cardiovascular complication in children with chronic kidney disease, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Assiut University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-08-01
|
| Completion Date: |
2018-12-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-06-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03202407
|
